Sign in Subscribe
Pediatrics

Pediatric Head and Neck Squamous Cell Carcinoma Study Provides Insights into Survival Outcomes and Prognostic Factors

Strategic Insights

— 1 min read

A new research study on pediatric head and neck squamous cell carcinoma (HNSCC) has offered a comprehensive analysis of the disease in children and adolescents. The study utilized data from the Surveillance, Epidemiology, and End Results (SEER) program, covering the period from 2000 to 2020, to examine the survival outcomes and prognostic factors associated with HNSCC in pediatric patients. The study found that nasopharyngeal HNSCC was associated with significantly better overall survival compared to oral cavity HNSCC, and that surgical treatment improved survival in oral cavity HNSCC cases.

Key Takeaways:

  • The study included 143 pediatric HNSCC cases, with an average age of 15.4 years at diagnosis and a predominance of male patients (65%).
  • Tumor distribution was nearly equal between the oral cavity (46.8%) and the nasopharynx (53.2%).
  • Nasopharyngeal HNSCC was associated with significantly better overall survival compared to oral cavity HNSCC (p=0.017).
  • Surgical treatment notably improved survival in oral cavity HNSCC cases (p=0.022).
  • Cox regression analysis revealed tumor site and chemotherapy as independent predictors of survival.
  • Pediatric HNSCC is a rare condition with diverse survival outcomes based on tumor location.

Statistics:

  • 143 pediatric HNSCC cases were identified in the study.
  • The average age of diagnosis was 15.4 years.
  • 65% of patients were male.
  • Tumors were distributed as follows: oral cavity (46.8%), nasopharynx (53.2%).
  • Nasopharyngeal HNSCC had a 17% higher overall survival rate than oral cavity HNSCC.

Sources:

  • Survival Outcomes and Prognostic Factors in Pediatric Head and Neck Squamous Cell Carcinoma: A Population-Based Study. Journal of Stomatology, Oral and Maxillofacial Surgery, 2025:102501.
  • Journal of Stomatology, Oral and Maxillofacial Surgery. Elsevier, Radarweg 29, 1043 Nx Amsterdam, Netherlands.
  • Department of Burn and Plastic Surgery. No. 903 Hospital of PLA Joint Logistic Support Force.

Read more